Asclemed recalls Lidolog Kit (2% Lidocaine injection) due to label wrap covering barcode, making scanning difficult. Affected units have specific lot and expiration dates.
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
✎ GovInfoNow plain-language explainer
Asclemed is recalling Lidolog Kit (2% lidocaine injection) because the label wrap covers the barcode, making it hard to scan. This issue doesn't pose a safety risk but could cause problems with product identification and prescription tracking. Read more at govinfonow.com/recall/92412-asclemed-lidolog-kit-recall-barcode-labeling-issue.
“Asclemed Lidolog Kit Recall: Barcode Labeling Issue.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/92412-asclemed-lidolog-kit-recall-barcode-labeling-issue. Based on FDA recall #D-0713-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0713-2026%22&limit=1).
The FDA announced on July 15, 2026, that Asclemed USA Inc. is recalling Lidolog Kits because the label wrap covers the barcode, making it hard to scan. This voluntary Class III recall affects 18 kits distributed in Tennessee.
How to tell if you have it
Brand: Asclemed
Product: Lidolog Kit
NDC: 76420-760-01
Lot: 070126X1
Expiration: 12/31/2027
The hazard
The label wrap covers the barcode, making it hard to scan. The FDA classified this as a Class III recall.
Context
GovInfoNow's records show Asclemed USA Inc. has issued two other recalls since May 14, 2026, including an Accucaine Lidocaine Injection recall on June 8, 2026, for lack of sterility assurance and a Duloxetine Capsules recall on May 14, 2026, for nitrosamine impurity risk. Other recent recalls of similar products include Eugia's lidocaine injection recall due to label scanning issues (May 18, 2026), American Regent's Levocarnitine Injection recall for a missing label hazard (April 16, 2026), and American Health Packaging's Buprenorphine Tablets recall for a label mix-up hazard (August 19, 2026).
How to tell if you have this one
Check for the kit containing 2% lidocaine injection (2mL vial, single-use). Look for lot number 070126X1 and expiration date 12/31/2027 on the label.
Brand
Asclemed
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Label
Look for lot number 070126X1 and expiration date 12/31/2027 on the label.
Where it went and when
Where it was distributed
Distributed in Tennessee.
Listed by the agency
Not listed
FDA distribution: “Within U.S. - Tennessee” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Tennessee.
Recall timeline
FDA published this recall 14 days after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0713-2026 (July 15, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0713-2026 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.